March 22, 2019
Two firms serving as class counsel in a junk fax settlement with Vertex Pharmaceuticals should receive less than they requested in fees because they overstated the $4.75 million deal's benefit to the class, a Massachusetts federal judge has ruled.
February 05, 2018
A Massachusetts federal judge was asked Friday to preliminarily approve Vertex Pharmaceuticals Inc.'s $4.75 million settlement to end putative class action claims the company violated the Telephone Consumer Protection Act by faxing unsolicited invitations to an event about its hepatitis C therapy.